Research Article
BibTex RIS Cite

INVESTIGATION OF THE EFFECTS OF EDUCATION ON DRUG COMPLIANCE AND TREATMENT FOR HYPERTENSIVE PATIENTS

Year 2022, Volume: 16 Issue: 4, 699 - 710, 23.12.2022
https://doi.org/10.21763/tjfmpc.1151712

Abstract

Aim: The purpose of this study is to investigate the effects of the education that was given to patients diagnosed with hypertension on the correct use of their medications, their follow-up visits, and their compliance with treatment. It was also aimed to observe how blood pressure, health perception, and anxiety level changed after education. Methods: For this intervention study, a questionnaire form including sociodemographic information, hypertension history, Medication Adherence Self-Efficacy Scale-Short Form (MASES-SF), Health Perception Scale (PHS), Health Anxiety Scale (HAI), and Modified Morisky Drug Compliance Scale (MMS), was applied at the beginning. Voluntarily, one by one, patients were grouped into education and non-education. The education given was a summary prepared from various guidelines. The blood pressures were measured three months later, and the questionnaires were applied except for demographic data six months later. Results: There were 49 patients divided into each group. In the education group, the mean MASES-SF score (36.28±10.08) increased to 40.65±8.57 (p<0.001), while the MMS knowledge level (1.63±0.48) increased to 1.79±0.40 (p=0.021) and the motivation level (1.40±0.48) increased to 1.77±0.42 (p<0.001). HAI score (33.10±12.76) decreased to 32.24±11.23 after the education (p=0.304). Systolic blood pressure and diastolic blood pressure decreased significantly after six months (p=0.003; p=0.022, respectively) in the education group. There were no significant changes in the blood pressure and drug compliance of the control group. Conclusion: This study showed that the knowledge-motivation level, health perception, and drug compliance increased with education.

References

  • 1. Aydoğdu S, Güler K, Bayram F, Altun B, Derici Ü, Abacı A, et al. Turkish hypertension consensus report. Turk Kardiyol Dern Ars 2019;47(6):535–546.
  • 2. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. ESC/ESH Guidelines for the management of arterial hypertension. Kardiol Pol 2018;77(2):71–159.
  • 3. World Health Organization. (‎2013)‎. A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. World Health Organization. [cited 09 August 2022]. Available from: https://apps.who.int/iris/handle/10665/79059
  • 4. Hipertansiyon tanı ve tedavi kılavuzu. Türkiye Endokrinoloji ve Metabolizma Derneği. Ankara, Tuna Matbaacılık (2019). [cited 09 August 2022]. Available from: https://temd.org.tr/yayinlar/kilavuzlar
  • 5. Irmak Z, Düzöz T, Bozyer İ. Effect of An Education Programme on the Lifestyle Change and Compliance to Drug Therapy of Hypertensive Patients. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi 2007;14(2):39-47.
  • 6. Fernbach V, James W, Mendel L, Reader G, Richards R, Shehan M, et al. The Concept of Planned, Hospital Based Patient Education Programs. Health Education Monographs. 1974;2(1):1-10. doi:10.1177/109019817400200102
  • 7. Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African American patients. J Clin Epidemiol 2003;56(6):520-529.
  • 8. Fernandez S, Chaplin, W, Schoenthaler AM, Ogedegbe G. Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med 2008;31(6):453-462.
  • 9. Hacihasanoglu R, Gözüm S, Çapik C. Validity of the Turkish version of the medication adherence self-efficacy scale-short form in hypertensive patients. Anatol J Cardiol 2012;12(3):241.
  • 10. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
  • 11. Vural B, Acar ÖT, Topsever P, Filiz TM. Reliability And Validity Of Turkish Version Of Modified Morisky Scale. Jour Turk Fam Phy 2012;3(4):17-20.
  • 12. Salkovskis PM, Rimes KA, Warwick HM, Clark DM. The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002;32:843-853.
  • 13. Aydemir Ö, Kırpınar İ, Satı T, Uykur B, Cengisiz C. Reliability and Validity of the Turkish Version of the Health Anxiety Inventory. Noro Psikiyatr Ars 2013;50:325-331.
  • 14. Diamond JJ, Becker JA, Arenson CA, Chambers CV, Rosenthal MP. Development of a scale to measure adults’ perceptions of health: priliminary findings. J Community Psychol 2007;35(5):557-61.
  • 15. Kadıoğlu H, Yıldız A. Validity and Reliability of Turkish Version of Perception of Health Scale. Türkiye Klinikleri J Med Sci. 2012;32:47-53. doi:10.5336/medsci.2010-21761
  • 16. Ergün UGÖ, Yildirim MY, Alparslan N. Drug Compliance and the Socio-economic Level Difference in the Essentially Hypertensive Patient. Türk Aile Hek Derg 2002;6(4):165-171.
  • 17. Demirbaş N, Kutlu R. Treatment Adherence and Self-efficacy Levels of Adults Using Multiple Drugs. Ankara Med J 2020;20(2):269-280.
  • 18. Özdemir Ö, Akyüz A, Doruk H. Compliance with drug treatment in geriatric patients with hypertension. Med J Bakirkoy 2016;12(4):195–201.
  • 19. Mollaoglu M, Solmaz G, Mollaoglu M. Adherence to therapy and quality of life in hypertensive patients. Acta Clin Croat 2015;54(4):438–443.
  • 20. Cingil D, Delen S, Aksuoğlu A. Evaluation of compliance and level of knowledge of patients with hypertension living in Karaman city center, Turkey. Turk Kardiyol Dern Ars 2009;37(8):551–556.
  • 21. Kankaya H, Özer S, Korkmaz M, Karabulut Ö, Kurt E. The medication adherence self-efficacy in elderly hypertensive patients. EGEHFD 2017;33(3):1-10.
  • 22. Kara DD, Ertan M, Uysal Y, Başhan İ. Evaluation of medication adherence in adults who use multiple medications in the context of illness perception, acknowledgement and attitude characteristics. TJFMPC 2017;11(4):227-234.
  • 23. Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PloS one 2013;8(4):e62775.
  • 24. Lulebo AM, Mutombo PB, Mapatano MA, Mafuta EM, Kayembe PK, Ntumba LT, et al. Predictors of non-adherence to antihypertensive medication in Kinshasa, Democratic Republic of Congo: a cross-sectional study. BMC Res Notes 2015;8(1):526.

HİPERTANSİF HASTALARDA EĞİTİMİN İLAÇ VE TEDAVİYE OLAN UYUMA ETKİSİNİN ARAŞTIRILMASI

Year 2022, Volume: 16 Issue: 4, 699 - 710, 23.12.2022
https://doi.org/10.21763/tjfmpc.1151712

Abstract

Amaç: Bu çalışmanın amacı hipertansiyon tanısı alan hastalara verilen eğitimin; ilaçlarını doğru kullanımına, takiplerine ve tedavi uyumlarına etkisini araştırmaktır. Ayrıca eğitim sonrasında sağlık algısının, kan basınçlarının ve anksiyete durumunun nasıl değiştiğini gözlemlemek amaçlanmıştır. Yöntem: Bu müdahale çalışmasında hastalara ilk başvuruda; hipertansiyon ile ilgili sorular, sosyodemografik bilgiler, Revize İlaca Uyum Öz-Etkililik Ölçeği-Kısa Form (MASES-SF), Sağlık Anksiyetesi Ölçeği, Sağlık Algısı Ölçeği (SAÖ) ve Modifiye Morisky İlaç Uyum Ölçeği’ni (MMÖ) içeren anket formu kullanıldı. Hastalar çalışmaya eğitim verilen ve eğitim verilmeyen olarak sırayla alındı. Çeşitli kılavuzların taranmasıyla oluşturulan bilgilerle eğitim verildi. İlk başvurudan üç ay sonra hastaların kan basınçları öğrenildi ve altı ay sonra demografik veriler hariç olmak üzere çalışmanın başında uygulanan anket formu tekrar uygulandı. Bulgular: Her gruba ayrılmış 49 hasta vardı. Eğitim grubunda, ilaç uyumu ölçeklerinden MASES-SF ölçeğinin ortalama puanı 36,28±10,08’den eğitim sonrasında 40,65±8,57 puana yükseldi (p<0,001). MMÖ bilgi düzeyi alt faktörü puan ortalaması 1,63±0,48 puandan eğitim sonrasında 1,79±0,40 puana yükseldi (p=0,021), MMÖ motivasyon düzeyi alt faktörü puan ortalaması 1,40±0,48 puandan eğitim sonrasında 1,77±0,42 puana yükseldi (p<0,001). Eğitim verilen grupta Sağlık Anksiyetesi ortalama puanı 33,10±12,76’dan eğitim sonrasında 32,24±11,23 puana geriledi (p=0,304). Eğitim verilen grupta altı aylık süreçte sistolik ve diyastolik kan basıncında anlamlı gerilemeler görüldü (sırasıyla p=0,003 ve p=0,022). Kontrol grubunda ise ilaç uyumu ve kan basıncında anlamlı bir değişiklik saptanmadı. Sonuç: Bu çalışma hastalara verilen eğitimle birlikte; bilgi-motivasyon düzeyinin, sağlık algısının ve ilaç uyumunun arttığını göstermiştir.

References

  • 1. Aydoğdu S, Güler K, Bayram F, Altun B, Derici Ü, Abacı A, et al. Turkish hypertension consensus report. Turk Kardiyol Dern Ars 2019;47(6):535–546.
  • 2. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. ESC/ESH Guidelines for the management of arterial hypertension. Kardiol Pol 2018;77(2):71–159.
  • 3. World Health Organization. (‎2013)‎. A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. World Health Organization. [cited 09 August 2022]. Available from: https://apps.who.int/iris/handle/10665/79059
  • 4. Hipertansiyon tanı ve tedavi kılavuzu. Türkiye Endokrinoloji ve Metabolizma Derneği. Ankara, Tuna Matbaacılık (2019). [cited 09 August 2022]. Available from: https://temd.org.tr/yayinlar/kilavuzlar
  • 5. Irmak Z, Düzöz T, Bozyer İ. Effect of An Education Programme on the Lifestyle Change and Compliance to Drug Therapy of Hypertensive Patients. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi 2007;14(2):39-47.
  • 6. Fernbach V, James W, Mendel L, Reader G, Richards R, Shehan M, et al. The Concept of Planned, Hospital Based Patient Education Programs. Health Education Monographs. 1974;2(1):1-10. doi:10.1177/109019817400200102
  • 7. Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African American patients. J Clin Epidemiol 2003;56(6):520-529.
  • 8. Fernandez S, Chaplin, W, Schoenthaler AM, Ogedegbe G. Revision and validation of the medication adherence self-efficacy scale (MASES) in hypertensive African Americans. J Behav Med 2008;31(6):453-462.
  • 9. Hacihasanoglu R, Gözüm S, Çapik C. Validity of the Turkish version of the medication adherence self-efficacy scale-short form in hypertensive patients. Anatol J Cardiol 2012;12(3):241.
  • 10. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
  • 11. Vural B, Acar ÖT, Topsever P, Filiz TM. Reliability And Validity Of Turkish Version Of Modified Morisky Scale. Jour Turk Fam Phy 2012;3(4):17-20.
  • 12. Salkovskis PM, Rimes KA, Warwick HM, Clark DM. The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002;32:843-853.
  • 13. Aydemir Ö, Kırpınar İ, Satı T, Uykur B, Cengisiz C. Reliability and Validity of the Turkish Version of the Health Anxiety Inventory. Noro Psikiyatr Ars 2013;50:325-331.
  • 14. Diamond JJ, Becker JA, Arenson CA, Chambers CV, Rosenthal MP. Development of a scale to measure adults’ perceptions of health: priliminary findings. J Community Psychol 2007;35(5):557-61.
  • 15. Kadıoğlu H, Yıldız A. Validity and Reliability of Turkish Version of Perception of Health Scale. Türkiye Klinikleri J Med Sci. 2012;32:47-53. doi:10.5336/medsci.2010-21761
  • 16. Ergün UGÖ, Yildirim MY, Alparslan N. Drug Compliance and the Socio-economic Level Difference in the Essentially Hypertensive Patient. Türk Aile Hek Derg 2002;6(4):165-171.
  • 17. Demirbaş N, Kutlu R. Treatment Adherence and Self-efficacy Levels of Adults Using Multiple Drugs. Ankara Med J 2020;20(2):269-280.
  • 18. Özdemir Ö, Akyüz A, Doruk H. Compliance with drug treatment in geriatric patients with hypertension. Med J Bakirkoy 2016;12(4):195–201.
  • 19. Mollaoglu M, Solmaz G, Mollaoglu M. Adherence to therapy and quality of life in hypertensive patients. Acta Clin Croat 2015;54(4):438–443.
  • 20. Cingil D, Delen S, Aksuoğlu A. Evaluation of compliance and level of knowledge of patients with hypertension living in Karaman city center, Turkey. Turk Kardiyol Dern Ars 2009;37(8):551–556.
  • 21. Kankaya H, Özer S, Korkmaz M, Karabulut Ö, Kurt E. The medication adherence self-efficacy in elderly hypertensive patients. EGEHFD 2017;33(3):1-10.
  • 22. Kara DD, Ertan M, Uysal Y, Başhan İ. Evaluation of medication adherence in adults who use multiple medications in the context of illness perception, acknowledgement and attitude characteristics. TJFMPC 2017;11(4):227-234.
  • 23. Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PloS one 2013;8(4):e62775.
  • 24. Lulebo AM, Mutombo PB, Mapatano MA, Mafuta EM, Kayembe PK, Ntumba LT, et al. Predictors of non-adherence to antihypertensive medication in Kinshasa, Democratic Republic of Congo: a cross-sectional study. BMC Res Notes 2015;8(1):526.
There are 24 citations in total.

Details

Primary Language English
Subjects ​Internal Diseases
Journal Section Orijinal Articles
Authors

Ahmet Emre Hatır 0000-0001-8094-3444

Nazan Karaoğlu 0000-0002-3057-2988

Yakup Alsancak 0000-0001-5230-2180

Publication Date December 23, 2022
Submission Date July 31, 2022
Published in Issue Year 2022 Volume: 16 Issue: 4

Cite

Vancouver Hatır AE, Karaoğlu N, Alsancak Y. INVESTIGATION OF THE EFFECTS OF EDUCATION ON DRUG COMPLIANCE AND TREATMENT FOR HYPERTENSIVE PATIENTS. TJFMPC. 2022;16(4):699-710.

English or Turkish manuscripts from authors with new knowledge to contribute to understanding and improving health and primary care are welcome.